| B3GAT3 |
Homo sapiens |
|
B3GAT3 is differentially expressed in 62 experiments [60 up/52 dn]: 17 organism parts: testis [1 up/0 dn], seminiferous tubule [1 up/0 dn], ...; 15 disease states: normal [1 up/3 dn], malignant melanoma [1 up/0 dn], ...; 12 cell types, 17 cell lines, 14 compound treatments and 13 other conditions. |
| B3GAT3 |
|
C47F8.4 (Caenorhabditis elegans)
C54C8.5 (Caenorhabditis elegans)
b3gat3 (Danio rerio)
NP_001121656.1 (Rattus norvegicus)
sqv-8 (Caenorhabditis elegans)
W07G9.2 (Caenorhabditis elegans)
GlcAT-P (Drosophila melanogaster)
GlcAT-S (Drosophila melanogaster)
B3gat3 (Mus musculus)
(Compare orthologs)
|
|
|
| Glycosyl transferase, family 43 |
|
|
| Golgi membrane, galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity, glycosaminoglycan biosynthetic process, manganese ion binding, membrane |
|
|
|
O94766
Q5U676
|
|
|
|
ENSG00000149541
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Normal
|
Disease state |
|
|
FLAP
|
Compound treatment |
|
|
HNRPA2B
|
Compound treatment |
|
|
MK886
|
Compound treatment |
|
|
PC3
|
Cell line |
|
|
Placebo
|
Compound treatment |
|
|
MCF7
|
Cell line |
|
|
SKBR3
|
Cell line |
|
|
Malignant melanoma
|
Disease state |
|
|
Hypericin incubated, not irrad...
|
Growth condition |
|
|
Hypericin incubated, irradiate...
|
Growth condition |
|
|
Kaposi's sarcoma-associated he...
|
Infection |
|
|
T47D
|
Cell line |
|
|
MDA468
|
Cell line |
|
|
Vascular smooth muscle cell
|
Cell type |
|
|
Chondrocyte
|
Cell type |
|
|
Testis
|
Organism part |
|
|
Estrogen receptor 1 positive; ...
|
Test result |
|
|
Johnsen score count 2: Sertoli...
|
Histology |
|
|
BT474
|
Cell line |
|
|
Seminiferous tubule
|
Organism part |
|
|
Glucocorticoid resistant
|
Phenotype |
|
|
Skeletal muscle
|
Organism part |
|
|
Cartilage
|
Organism part |
|
|
HPL1
|
Cell line |
|
|
Heregulin
|
Compound treatment |
|
|
Spermatid
|
Cell type |
|
|
Control for heregulin
|
Compound treatment |
|
|
Epidermal growth factor
|
Compound treatment |
|
|
Benign prostatic hyperplasia
|
Disease state |
|
|
Prostate carcinoma
|
Disease state |
|
|
Primary cells
|
Cell line |
|
|
Selenium
|
Compound treatment |
|
|
Clear cell sarcoma of the kidn...
|
Disease state |
|
|
Spermatocyte
|
Cell type |
|
|
Baseline uninfected
|
Disease state |
|
|
Plasma cell
|
Cell type |
|
|
B lymphocyte
|
Cell type |
|
|
HL-60
|
Cell line |
|
|
Superficial transitional cell ...
|
Disease state |
|
|
Prefrontal cortex
|
Organism part |
|
|
Estrogen receptor 1 negative; ...
|
Test result |
|
|
Tumor
|
Organism part |
|
|
MCF10A
|
Cell line |
|
|
HaCaT
|
Cell line |
|
|
Glioblastoma
|
Disease state |
|
|
White blood cell
|
Cell type |
|
|
Platelet
|
Cell type |
|
|
Atrial mycocardium
|
Organism part |
|
|
Ventricular myocardium
|
Organism part |
|
|
Carcinoma in situ lesion
|
Disease state |
|
|
Lymphatic endothelial cell
|
Cell type |
|
|
Grade IV
|
Tumor grading |
|
|
Esophageal adenocarcinoma
|
Disease state |
|
|
ERalpha transfected
|
Genotype |
|
|
ERalpha L540Q transfected
|
Genotype |
|
|
Johnsen score count 10: full s...
|
Histology |
|
|
Cystic change
|
Histology |
|
|
None
|
Compound treatment |
|
|
Lipopolysaccharide
|
Compound treatment |
|
|
Uninfected
|
Infection |
|
|
Phorbol 12-myristate 13-acetat...
|
Compound treatment |
|
|
Estrogen receptor 1 positive; ...
|
Test result |
|
|
MCF-7
|
Cell line |
|
|
Monocyte at intermediate diffe...
|
Cell type |
|
|
Control
|
RNAi |
|
|
SIM2s
|
RNAi |
|
|
Frontal cortex, superior motor...
|
Organism part |
|
|
Normal1
|
Replicate |
|
|
Breast carcinoma
|
Disease state |
|
|
Johnsen score count 3.2: Serto...
|
Histology |
|
|
Granulocyte
|
Cell type |
|
|
MDA-MB-231
|
Cell line |
|
|
Superior cervical ganglion
|
Organism part |
|
|
Homo sapiens
|
Organism |
|
|
Capra hircus
|
Organism |
|
|
CD11c+ dendritic cell
|
Cell type |
|
|
Whole blood
|
Organism part |
|
|
Not applicable
|
Histology |
|
|
Whole brain
|
Organism part |
|
|
Ethanol
|
Vehicle |
|
|
Glucocorticoid sensitive
|
Phenotype |
|
|
YCC16
|
Cell line |
|
|
BCBL-1
|
Cell line |
|
|
Effector memory CD4 T cell
|
Target cell type |
|
|
Aggregatibacter actinomycetemc...
|
Infection |
|
|
Trigeminal ganglion
|
Organism part |
|
|
Growth medium
|
Vehicle |
|
|
Acute malaria, natural infecti...
|
Disease state |
|
|
R-(-)-apomorphine HCl
|
Compound treatment |
|
|
Lymphoid tissue
|
Organism part |
|
|
Bone marrow
|
Organism part |
|
|
BC-3
|
Cell line |
|
|
Cerebellum
|
Organism part |
|
|
Glutamine
|
Compound treatment |
|
|
T-cell lymphoblastic lymphoma
|
Disease state |
|
|
Vasectomized
|
Clinical history |
|
|
N/a
|
Test result |
|
|
Muscle invasive carcinoma
|
Disease state |
|
|
Johnsen score count 5: no sper...
|
Histology |
|
|
Lung
|
Organism part |
|
|
5-fluorouridine
|
Compound treatment |
|
|
YCC6
|
Cell line |
|
|
Crohn's disease
|
Disease state |
|
|
|
|
|
Processing time: 0.131 secs.